Choline, a component of cell membranes and a precursor for acetylcholine, is involved in brain development, neurotransmission, and signaling
Providing persons living with AD/ADRD and their caregivers and care partners with plenty of opportunities to ask questions, reiterating important trial details throughout the entirety of their involvement, as well as clearly communicating the risks and benefits of participation, are all strategies that can help people feel more empowered to make informed decisions and reduce some of the uncertainties and anxieties surrounding clinical trial enrollment (Connell et al., 2001
Serious Adverse Events and Discontinuation Signals In TRANSCEND-T2D-1, Lilly reported adverse-event discontinuation rates of 2.2%, 4.5%, and 5.1% with retatrutide 4 mg, 9 mg, and 12 mg, compared with 0.0% with placebo [9]
Roslan J, Giribabu N, Karim K, Salleh N
In Larkin v
FAQ about MC Prof